Almitas Capital LLC I Teos Therapeutics, Inc. Call Options Transaction History
Almitas Capital LLC
- $212 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ITOS
# of Institutions
131Shares Held
37.5MCall Options Held
733KPut Options Held
611K-
Eco R1 Capital, LLC San Francisco, CA10.7MShares$108 Million9.18% of portfolio
-
Tang Capital Management LLC San Diego, CA3.83MShares$38.8 Million2.28% of portfolio
-
Black Rock Inc. New York, NY3.73MShares$37.9 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY1.98MShares$20.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$16.9 Million0.0% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $361M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...